down arrow

Mangalam Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE584F01014
  • NSEID: MANGALAM
  • BSEID: 532637
INR
75.50
0.85 (1.14%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 8.82 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Net Sales
368.59
Other Operating Income
0.00
Total Operating income
368.59
Raw Material Cost
224.76
Purchase of Finished goods
10.65
(Increase) / Decrease In Stocks
9.10
Employee Cost
39.07
Power Cost
0.00
Manufacturing Expenses
0.00
Selling and Distribution Expenses
0.00
Other Expenses
67.62
Total Expenditure (Excl Depreciation)
351.20
Operating Profit (PBDIT) excl Other Income
17.39
Other Income
0.10
Operating Profit (PBDIT)
17.49
Interest
13.92
Exceptional Items
0.00
Gross Profit (PBDT)
3.57
Depreciation
14.65
Profit Before Tax
-11.07
Tax
-2.00
Provisions and contingencies
0.00
Profit After Tax
-9.07
Extraordinary Items
0.00
Prior Period Expenses
0.00
Other Adjustments
0.00
Net Profit
-9.07
Share in Profit of Associates
0.00
Minority Interest
0.00
Other related items
0.00
Consolidated Net Profit
-9.07
Equity Capital
15.83
Face Value
10.0
Reserves
119.96
Earnings per share (EPS)
-5.73
Diluted Earnings per share
-5.73
Operating Profit Margin (Excl OI)
4.73%
Gross Profit Margin
0.97%
PAT Margin
-2.47%
Public Share Holdings (%)
0.0%
Pledged Promotor Holding (%)
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is -0.77% vs -17.89% in Mar 2023

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2024 is -812.60% vs -93.54% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is -32.41% vs -47.55% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 7.41% vs 16.13% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2024 has fallen from Mar 2023

Compare Annual Results Of Mangalam Drugs With
Markets Mojo
Figures in Rs cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
368.59
10,334.77
-9,966.18
-96.43%
Other Operating Income
0.00
0.00
0.00
Total Operating income
368.59
10,334.77
-9,966.18
-96.43%
Raw Material Cost
224.76
1,853.52
-1,628.76
-87.87%
Purchase of Finished goods
10.65
1,409.85
-1,399.20
-99.24%
(Increase) / Decrease In Stocks
9.10
-53.67
62.77
116.96%
Employee Cost
39.07
2,274.73
-2,235.66
-98.28%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
67.62
2,315.28
-2,247.66
-97.08%
Total Expenditure (Excl Depreciation)
351.20
7,799.71
-7,448.51
-95.50%
Operating Profit (PBDIT) excl Other Income
17.39
2,535.06
-2,517.67
-99.31%
Other Income
0.10
280.86
-280.76
-99.96%
Operating Profit (PBDIT)
17.49
2,815.92
-2,798.43
-99.38%
Interest
13.92
33.53
-19.61
-58.48%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
3.57
2,782.39
-2,778.82
-99.87%
Depreciation
14.65
398.25
-383.60
-96.32%
Profit Before Tax
-11.07
2,384.14
-2,395.21
-100.46%
Tax
-2.00
457.58
-459.58
-100.44%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-9.07
1,926.56
-1,935.63
-100.47%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-9.07
1,926.56
-1,935.63
-100.47%
Share in Profit of Associates
0.00
15.21
-15.21
-100.00%
Minority Interest
0.00
-28.87
28.87
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-9.07
1,912.90
-1,921.97
-100.47%
Equity Capital
15.83
40.06
-24.23
-60.48%
Face Value
10.00
1.00
0.00
Reserves
119.96
9,323.03
-9,203.07
-98.71%
Earnings per share (EPS)
-5.73
47.75
-53.48
-112.00%
Diluted Earnings per share
-5.73
47.68
-53.41
-112.02%
Operating Profit Margin (Excl OI)
4.73%
24.53%
0.00
-19.80%
Gross Profit Margin
0.97%
26.92%
0.00
-25.95%
PAT Margin
-2.47%
18.79%
0.00
-21.26%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 367.35 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -0.77% vs -17.89% in Mar 2023

Annual - Standalone Net Profit
Standalone Net Profit -9.05 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -812.60% vs -93.54% in Mar 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.39 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -32.41% vs -47.55% in Mar 2023

Annual - Interest
Interest 13.92 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 7.41% vs 16.13% in Mar 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.73%
in Mar 2024

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2024 has fallen from Mar 2023